JHIU
SGYP

Janus Henderson Investors US’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Janus Henderson Investors US’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-218,574
Closed -$1.81M – 1217
2015
Q2 		$1.81M Buy
+218,574
New +$1.06M ﹤0.01% 914

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Investors US's SGYP Position: Q3 2015 in Review

Janus Henderson Investors US sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015, closing a stake of 218,574 shares — an estimated $1.81M sold.

Janus Henderson Investors US first reported a position in SGYP in Q2 2015 and held it in 1 quarter. The position peaked at $1.81M in Q2 2015. 129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

  • Janus Henderson Investors US reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2015 after selling out during the quarter.
  • Janus Henderson Investors US sold 218,574 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2015, an estimated $1.81M.
  • Janus Henderson Investors US first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 1 quarter.
  • Janus Henderson Investors US's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.81M in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Janus Henderson Investors US's 13F filing for Q3 2015, filed 17 Nov 2015.